Navigation Links
Medbox Announces Increase in Shareholder Base and Record Revenue Generated in Q3

HOLLYWOOD, Calif., Nov. 2, 2012 /PRNewswire/ -- Medbox, Inc. (Ticker: MDBX) ( announced that they have increased their shareholder base last quarter by over 30%. The announcement comes at a time of significant additions to the company's product line, as well the launch of a new division dedicated to serving the healthcare and pharmaceutical industries.

The new shareholders have come on board at an opportune time - before the company's planned move up from the Pink Sheets to the OTC Bulletin Board. As part of this process, the company is in the midst of an audit in order to comply with the fully reporting standards set forth by the SEC.

In addition, the company has reported a record setting 3rd quarter, generating over $1.3 million in revenue and its highest EBITDA margin to date.

"We are thrilled to have so many new people join our family of shareholders," stated Dr. Bruce Bedrick, CEO of Medbox, Inc. "With our lineup of exciting new products, solid revenue growth, and specialized divisions to target specific industry sectors, it is no wonder that people from all over the world are starting to invest with our company."

In the coming months Medbox will be announcing exciting dividend programs for its shareholders upon the company meeting some of its performance goals. In addition, once the JOBS act is enacted by the SEC later this year, the company will be publicly announcing its plans to incentivize new accredited investors that acquire shares directly from the company.  

For more information, contact Medbox Investor Relations at: (800) 762-1452.

About Medbox, Inc: 

Medbox is a leader in the development, sales and service of automated, biometrically controlled dispensing and storage systems for medicine and merchandise. Medbox has offices throughout the world, including New York, Tokyo, London and Toronto, and has their corporate headquarters in Los Angeles.

Medbox provides their patented systems, software and consulting services to pharmacies, urgent care centers, clinics, hospitals, and medical groups worldwide.

Medbox, Inc. is a publicly traded company, and is listed on the OTC Board, ticker symbol MDBX.

For more information on Medbox, please contact the Medbox Investor Relations Department at (800) 762-1452 or go online to

SOURCE Medbox, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Medbox, Inc. at the Forefront of Providing Secure Medicine Dispensing Systems to Prisons
2. Medbox, Inc. To Support Referendum Overturning LA City Council Ban on Medical Marijuana Outlets
3. Medbox, Inc. Weighs-in on FDA Evaluation of Prescription Medicine Dispensing Systems
4. Medbox, Inc. Rides a Wave of Local Media Support in Connecticut
5. Cardinal Health Announces Preliminary Shareholder Voting Results at 2012 Annual Meeting
6. Aviv REIT Announces Acquisition Of Skilled Nursing Facility With New Tenant Relationship NuCare
7. Omthera Pharmaceuticals Announces Invitation to Attend Presentation of the Complete Data Sets from its Phase 3 EVOLVE and ESPRIT Clinical Studies
8. UBM Medica India Announces Hospital Management Conference (HMC) 2012
9. CardioInsight Announces Appointment of Patrick J. Wethington as President & Chief Executive Officer
10. Medela Announces Virtual Breast Milk Collection Campaign in Honor of Prematurity Awareness Month
11. Janssen Announces Collaboration with Vertex on Phase 2 Study to Investigate an All-Oral Regimen of Simeprevir (TMC435) and VX-135 for Treatment of Hepatitis C
Post Your Comments:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... Improvements Act of 1976, as amended ("HSR"), with respect ... Nasdaq: CPXX ) expired effective June 24, ... As previously announced on May 31, 2016, Jazz Pharmaceuticals ... which Jazz Pharmaceuticals has commenced a tender offer for ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... 2016 , ... The OSHA Training Center at Chabot-Las ... headquartered in Northern California, has issued an important reminder to employers to prevent ... Employers with workers exposed to high temperatures should establish a complete heat illness ...
(Date:6/27/2016)... Viejo, California (PRWEB) , ... June 27, 2016 , ... ... are fully customizable inside of Final Cut Pro X," said Christina Austin - CEO ... another unique style. Final Cut Pro X users can now reveal the ...
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/27/2016)... ... June 27, 2016 , ... A revolution ... the emergency ambulance transport experience for the millions of people who require these ... disrupted the taxi industry through the use of technology. Now, SmartEMS has put ...
Breaking Medicine News(10 mins):